Viruses and cancer: Lessons from the human polyomavirus, JCV

Oncogene

Volumn 22, Issue 43, 2003, Pages 6517-6523

  Reiss, Krzysztof ^a   Khalili, Kamel ^a  

^a TEMPLE UNIVERSITY   (United States)

Author keywords

JC virus; Oncogene; PML; T antigen; Tumorigenesis

Indexed keywords

BETA CATENIN; CYCLIN DEPENDENT KINASE; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN P53; RETINOBLASTOMA PROTEIN; SOMATOMEDIN C; TRANSCRIPTION FACTOR; VIRUS DNA; VIRUS PROTEIN; VIRUS SMALL T ANTIGEN; WNT PROTEIN;

ANIMAL MODEL; CELL CYCLE; CELL PROLIFERATION; CELL TRANSFORMATION; CENTRAL NERVOUS SYSTEM; DNA REPLICATION; ENZYME ACTIVATION; JC VIRUS; NONHUMAN; ONCOGENE; POLYOMA VIRUS; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; TUMOR SUPPRESSOR GENE; VIRUS CARCINOGENESIS; VIRUS GENOME; VIRUS INFECTION; VIRUS TRANSFORMATION;

ANIMALIA; DNA VIRUSES; EUKARYOTA; JC VIRUS; POLYOMAVIRUS;

EID: 0242539822     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1206959     Document Type: Review

References (67)

1. Baserga R. (1999). Exp. Cell Res., 253, 1-6.
2. Berger JR and Concha M. (1995). J. Neurovirol., 1, 5-18.
3. Berger JR, Levy RM, Flomenhoft D and Dobbs M. (1998). Ann. Neural., 44, 341-349.
4. Bofill-Mas S, Formiga-Cruz M, Clemente-Casares P, Calafell F and Girones R. (2001). J. Virol. 75, 10290-10299.
5. Bollag B, Chuke W-F and Frisque RJ. (1989). J. Virol., 63, 863-872.
6. Bollag B, Prins C, Snyder EL and Frisque RJ. (2000). Virology, 274, 165-178.
7. Carswell S and Alwine JC. (1986). J. Virol., 60, 1055-1061.
8. Castaigne P, Rondot P, Escourolle R, Ribadeau Dumas J-L, Cathala F and Hauw J-J. (1974). Rev. Neurol. Paris, 130, 379-392.
9. Darbinian N, Gallia GL, King J, Del Valle L, Johnson EM and Khalili K. (2001). J. Cell. Physiol., 189, 334-340.
10. Del Valle L, Gordon J, Ferrante P and Khalili K. (2001a). Human Polyomaviruses: Molecular and Clinical Perspectives. Stoner GL, Khalili K. (eds). John Wiley & Sons, Inc.: New York, pp. 409-430.
11. Del Valle L, Gordon J, Assimakopoulou M, Enam S, Geddes JF, Varakis J, Katsetos CD, Croul S and Khalili K. (2001b). Cancer Res., 61, 4287-4293.
12. Del Valle L, Enam S, Lassak A, Wang J-Y, Croul S, Khalili K and Reiss K. (2002a). Clin. Cancer Res., 8, 1822-1830.
13. Del Valle L, Wang JY, Lassak A, Peruzzi F, Croul S, Khalili K and Reiss K. (2002b). J. Neurovirol., 8 (Suppl. 2), 138-147.
14. Del Valle L, Gordon J, Enam S, Delbue S, Croul S, Abraham S, Radhakrishnan S, Assimakoupoulou M, Katsetos CD and Khalili K. (2002c). J. Natl. Cancer Inst., 94, 267-273.
15. Eberhart CG, Tihan T and Burger PC. (2000). J. Neuropathol. Exp. Neural., 59, 333-337.
16. Enam S, Del Valle L, Lara C, Gan DD, Ortiz-Hidalgo C, Palazzo JP and Khalili K. (2002). Cancer Res., 62, 7093-7101.
17. Fareed GC, Takemoto KK and Gimbrone Jr MA. (1978). Microbiology, Schlessinger D (ed). American Society for Microbiology: Washington, DC, pp. 427-431.
18. Franks RR, Rencic A, Gordon J, Zoltick PW, Curtis M, Knobler RL and Khalili K. (1996). Oncogene, 12, 2573-2578.
19. Frisque RJ and White III FA. (1992). Molecular Neurovirology. Roos RP. (ed). Humana Press: Totowa, NJ, pp. 25-158.
20. Frisque RJ, Rifkin DB and Walker DL. (1980). J. Virol., 35, 265-269.
21. Gallia GL, Gordon J and Khalili K. (1998a). J. Neurovirol., 4, 175-181.
22. Gallia GL, Safak M and Khalili K. (1998b). J. Biol. Chem., 273, 32662-32669.
23. Gan DD, Reiss K, Gorrill T, Del Valle L, Croul S, Giordano A, Fishman P and Khalili K. (2001). Oncogene, 20, 4864-4870.
24. Gao ZH, Seeling JM, Hill V, Yochum A and Virshup DM. (2002). Proc. Natl. Acad. Sci. USA, 99, 1182-1187.
25. Gordon J, Del Valle L, Otte J and Khalili K. (2000). Oncogene, 19, 4840-4846.
26. Haggerty S, Walker DL and Frisque RJ. (1989). J. Virol., 63, 2180-2190.
27. He TC, Sparks AB, Rago C, Hermeking H, Zawel L, da Costa LT, Morin PJ, Vogelstein B and Kinzler KW. (1998). Science, 281, 1509-1512.
28. Howard CM, Claudio PP, Gallia GL, Gordon J, Giordano GG, Hauck WW, Khalili K and Giordano A. (1998). J. Natl. Cancer. Inst., 90, 1451-1460.
29. Kang S and Folk WR. (1992). Virology, 191, 754-764.
30. Khalili K, Brady J, Papas J, Spence S, Sadofsky M and Khoury G. (1988). Proc. Natl. Acad. Sci. USA, 85, 354-358.
31. Krynska B, Del Valle L, Croul S, Gordon J, Katsetos K, Carbone M, Giordano A and Khalili K. (1999a). Proc. Natl. Acad. Sci. USA, 96, 11519-11524.
32. Krynska B, Otte J, Franks R, Khalili K and Croul S. (1999b). Oncogene, 18, 39-46.
33. Krynska B, Del Valle L, Gordon J, Otte J, Croul S and Khalili K. (2000). Virology, 274, 65-74.
34. Lassak A, Del Valle L, Peruzzi F, Wang JY, Croul S, Khalili K and Reiss K. (2002). J. Biol. Chem., 277, 17231-17238.
35. London WT, Houff SA, McKeever PE, Wallen WC, Sever JL, Padgett BL and Walker DL. (1983). Prog. Clin. Biol. Res., 105, 227-237.
36. Major EO, Amemiya K, Tornatore CS, Houff SA and Berger JR. (1992). Clin. Microbiol. Rev., 5, 49-73.
37. Monaco MC, Atwood WJ, Gravell M, Tornatore CS and Major EO. (1996). J. Virol., 70, 7004-7012.
38. Morin PJ. (1999). BioEssays, 21, 1021-1030.
39. Ohsumi S, Motoi M and Ogawa K. (1986). Acta Pathol. Jpn., 36, 815-825.
40. Patti R, Reddy CD, Geoerger B, Grotzer MA, Raghunath M, Sutton LN and Phillips PC. (2000). Int. J. Oncol., 16, 577-584.
41. Pipas JM. (1992). J. Virol., 66, 3979-3985.
42. Polakis P. (2000). Genes Dev., 14, 1837-1851.
43. Prins C and Frisque RJ. (2001). J. Neurovirol., 7, 250-264.
44. Raj G, Gordon J, Logan TJ, Hall D, Chang C-F, Sala A, De Luca A, Giordano A and Khalili K. (1995). Int. J. Oncol., 7, 801-808.
45. Reiss K. (2002). Exp. Opin. Ther. Targets, 6, 539-544.
46. Resnick J and Shenk T. (1986). J. Virol., 60, 1098-1106.
47. Riccardiello L, Chang DK, Laghi L, Goel A, Chang CL and Boland R. (2001). J. Virol., 75, 1996-2001.
48. Ricciardiello L, Laghi L, Ramamirtham P, Chang CL, Chang DK, Randolph AE and Boland CR. (2000). Gastroenterology, 119, 1228-1235.
49. Richardson Jr EP. (1961). N. Engl. J. Med., 265, 815-823.
50. Safak M, Gallia GL, Ansari SA and Khalili K. (1999). J. Virol., 73, 10146-10157.
51. Safak M, Barrucco R, Darbinyan A and Khalili K. (2001). J. Virol., 75, 1476-1486.
52. Sheaff RJ, Groudine M, Gordon M, Roberts JM and Clurman BE. (1997). Genes Dev., 11, 1464-1478.
53. Shintaku M, Matsumoto R, Sawa H and Nagashima K. (2000). J. Neuropathol. Exp. Neurol., 59, 921-929.
54. Shtutman M, Zhurinsky J, Simcha I, Albanese C, D'Amico M, Pestell R and Ben-Ze'ev A. (1999). Proc. Natl. Acad. Sci. USA, 96, 5522-5527.
55. Sima AAF, Finkelstein SD and McLachlan DR. (1983). Ann. Neurol., 14, 183-188.
56. Small JA, Khoury G, Jay G, Howley PM and Scangos GA. (1986a). Proc. Natl. Acad. Sci. USA, 83, 8288-8292.
57. Small JA, Scangos GA, Cork L, Jay G and Khoury G. (1986b). Cell, 46, 13-18.
58. Sontag E, Fedorov S, Kamibayashi C, Robbins D, Cobb M and Mumby M. (1993). Cell, 75, 887-897.
59. Sullivan CS, Tremblay JD, Fewell SW, Lewis JA, Brodsky JL and Pipas JM. (2000). Mol. Cell. Biol., 20, 5749-5757.
60. Tu X, Batta P, Innocent N, Prisco M, Casaburi I, Belletti B and Baserga R. (2002). J. Biol. Chem., 277, 44357-44365.
61. Varakis J, Zu Rhein GM, Padgett BL and Walker DL. (1978). Cancer Res., 36, 1718-1722.
62. Walker DL and Padgett BL. (1978). Microbiology, Schlessinger D (ed). American Society for Microbiology: Washington, DC, pp. 432-434.
63. Walker DL, Padgett BL, ZuRhein GM, Albert AE and Marsh RF. (1973). Science, 181, 674-676.
64. Wang JY, Del Valle L, Gordon J, Rubini M, Croul S, Peruzzi F, Khalili K and Reiss K. (2001). Oncogene, 20, 3857-3868.
65. Wheat WH, Roesler WJ and Klemm DJ. (1994). Mol. Cell. Biol., 14, 5881-5890.
66. Zerfass-Thome K, Schulze A, Zwerschke W, Vogt B, Helin K, Bartek J, Henglein B and Jansen-Durr P. (1997). Mol. Cell. Biol., 17, 407-415.
67. Zu Rhein GM and Varakis JN. (1979). Perinatal Carcinogenesis: National Cancer Institute Monograph, Vol. 51. Rice JM (ed). National Cancer Institute: Bethesda, MD, pp. 205-221.